DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
.....
I was 90 percent paralysed in dec,2007 by one in a million stoke, acute transverse mylitis and bound to a wheel chair. I am commited to helping others
Lionel was only in first standard of school in dec2007 when I was terribly paralysed, only my fingers recovered and now able to bring you updates, I am now widely read and have millions of followers, thanks for helping me to keep lionel smiling
ANTHONY MELVIN CRASTO
For paypal
Mobile Number +919323115463 INDIA
Email ID amcrasto@gmail.com
I was 90 percent paralysed in dec,2007 by one in a million stoke, acute transverse mylitis and bound to a wheel chair. I am commited to helping others
Lionel was only in first standard of school in dec2007 when I was terribly paralysed, only my fingers recovered and now able to bring you updates, I am now widely read and have millions of followers, thanks for helping me to keep lionel smiling
MY BANK details are as follows
1) Name of the Account Holder ANTHONY MELVIN CRASTO
2) Bank Name AXIS BANK
3) Full Bank Account Number(without/or any special character) 072010100147507
4) IFSC Code UTIB0000772, SWIFT CODE =AXISINBB571
5) Account Type SAVINGS
6) Bank Address Ghodbunder Road, Thane, Maharashtra, India 400607
7) Mobile Number +919323115463 INDIA
8) Email ID amcrasto@gmail.com
THANKS AND REGARD’S
DR ANTHONY MELVIN CRASTO Ph.D
amcrasto@gmail.com
MOBILE-+91 9323115463
GLENMARK SCIENTIST , INDIA
web link
NEW DRUG APPROVALS
one time
$100.00
Web link
ACCOLADES
NUMBER 1
| Stevie Cafferkey <stevie.cafferkey@sei-healthcare.com> | 12:56 (1 hour ago)  | 3 RD MARCH 2018 | |
| to me |
Dear Dr. Crasto, I wanted to reach out to you firstly, to commend you on the website, newdrugapprovals.org. I have found this to be extremely helpful with our research. The key mandate in my current position here at SEI Healthcare is to expand our business operations into APAC, focusing on Medical Education campaigns focused on newly approved drugs in this region. I am however, finding it extremely challenging when I search into each individual country’s Drug Agency, so I wanted to ask your opinion on how might I be able to stay abreast of all newly approved drugs and diagnostics into each country (particularly the major markets)? At present, I am finding it very difficult to locate where to find databases or news pertaining to drug approvals in the following locations. New Zealand Korea Hong Kong/ China Japan Your advice and guidance would be greatly appreciated. Kind regards, Steve
—
Stevie Cafferkey Medical Associate Director
E: stevie.cafferkey@sei-healthcare.com W:www.sei-healthcare.com M: +65 9819 4494 T: +44 2081336981 Sei-Healthcare: This message (including any attachments) may contain confidential, proprietary, privileged and/or private information. The information is intended to be for the use of the individual or entity designated above. If you are not the intended recipient of this message, please notify the sender immediately, and delete the message and any attachments. Any disclosure, reproduction, distribution or other use of this message or any attachments by an individual or entity other than the intended recipient is prohibited.
NUMBER 2
| margaret beveridge<margaret@margaretbeveridge.com> | 14 Mar (2 days ago)2018 |
| to me |
Dear Anthony,
I am sorry to hear from your website that you are suffering from transverse myelitis and I wish you well.
The reason for my visit to your website is that I am looking for a source of VX-659, the next generation of CF treatment, which is to be used in combination with VX-770 (ivacaftor) and VX-661 (tezacaftor), the synthesis of which you have very expertly detailed.
Do you think it is possible to manufacture VX-659?
With very best regards,
Margaret
NUMBER 3
| Alexander Batthyany <alexander.batthyany@gmail.com> | 17:53 (15 hours ago) aug 4 2018 | ||
| to me |
Dear Dr Crasto,
I have been following and reading your websites for quite a while, and before I come to my main reason of writing, would like to express my admiration for your activities, and for your approach to cope with your physical condition. Thank you!
It is also an incredibly nice move of you to make your wide knowledge on medical chemistry available to the many. I am very grateful for that, and no doubt you thus help many thousands of people.
Now to my reason for writing: I am trying to find out more about EPI-743, i.e. Vatiquinone, and its production. I hope you do not mind if I ask you a few questions on it:
- Do you know, or where can I find out, whether Vatiquinone is a patented substance in Europe?
- What do you know about the process of manufacturing the substance oneself in the lab? Is this a complex or difficult process?
In case you wonder why I am asking – our family is affected by a type of mitochondrial disease which may well profit from EPI-743 (according to published studies), yet the substance itself is, currently at least, inaccessible and there are no clinical trials running at the moment. As we are engaged in a race against time, literally, I thus wonder about other ways to get access to Vatiquinone, especially given its relative excellent profile when it comes to side effects, etc.
I am very much looking forward to hearing from you –
Best, Alexander Batthyany
—
Dr. Alexander Batthyany
Prinz Eugenstr. 18
1040 Vienna
NUMBER 4
WILL BE ADDED……..
New Drug Approvals 